Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

American Journal of Respiratory and Critical Care Medicine

Volumn 152, Issue 5 I, 1995, Pages 1467-1473

  Noonan, Michael ^a   Chervinsky, Paul ^a   Busse, William W ^a   Weisberg, Steven C ^a   Pinnas, Jacob ^a   De Boisblanc, Bennett P ^a   Boltansky, Howard ^a   Pearlman, David ^a   Repsher, Lawrence ^a   Kellerman, Donald ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE PROPIONATE; PLACEBO; PREDNISONE; SALBUTAMOL; TRIAMCINOLONE ACETONIDE;

AEROSOL; ARTICLE; ASTHMA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HOARSENESS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SORE THROAT;

EID: 0028846147     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.152.5.7582278     Document Type: Article

References (34)

1. Skorodin, M. S. 1993. Pharmacotherapy for asthma and chronic obstructive pulmonary disease: current thinking, practices, and controversies. Arch. Int. Med. 153:814-828.
2. Kemp, J. P. 1993. Approaches to asthma management: realities and recommendations. Arch. Int. Med. 153:805-812.
3. Cott, G. R., and R. M. Cherniack. 1988. Steroids and "steroid-sparing" agents in asthma. N. Engl. J. Med. 318:634-636.
4. Kwong, F. K., M. A. Sue, and W. B. Klaustermeyer. 1987. Corticosteroid complications in respiratory disease. Ann. Allergy 58:326-330.
5. Truhan, A. P., and A. R. Ahmed. 1989. Corticosteriods: a review with emphasis on complications of prolonged systemic therapy. Ann. Allergy. 62:375-390.
6. Expert Panel on the Management of Asthma. 1991. Approaches to asthma therapy. J. Allergy Clin. Immunol. 88(Part II):425-534.
7. Baiter, M. S., and A. S. Rebuck. 1989. Treatment of the recalcitrant asthmatic. Ann. Allergy 63:297-300.
8. Neirop, G., W. P. Gijzel, E. H. Bel, A. H. Awinderman, and J. H. Dijkman. 1992. Auranaofin in the treatment of steroid dependent asthma: a double blind study. Thorax 47:349-354.
9. Trigg, C. J., and R. J. Davies. 1993. Comparison of methotrexate 30 mg per week with placebo in chronic steroid-dependent asthma: a 12-week double-blind cross-over study. Respir. Med. 87:211-216.
10. Dyer, P. D., T. R. Vaughan, and R. W. Weber. 1991. Methotrexate in the treatment of steroid-dependent asthma. J. Allergy Clin. Immunol. 88:208-212.
11. H. Chestnut, M. S., and S. C. Lazarus. 1992. Asthma therapy in the nineties: focus on inflammation. Hospital Formulary 27:466-482.
12. Grossman, J., C. A. Sorkness, and J. C. Joseph. 1992. The use of inhaled corticosteriods in patients with asthma. Drug Therapy 22:37-52.
13. Lacronique, J., D. Renon, D. Georges, M. Henry-Amar, and J. Marsac. 1991. High-dose beclomethasone: oral steroid-sparing effect in severe asthmatic patients. Eur. Respir. J. 4:807-812.
14. Tarlo, S. M., K. Broder, G. M. Davies, A. Leznoff, S. Mintz, and P. N. Corey. 1988. Six-month double-blind, controlled trial of high dose, concentrated beclomethasone dipropionate in the treatment of severe chronic asthma. Chest 93:998-1002
15. Phillipps, G. H. 1990. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir. Med. 84(Suppl. A):19-23.
16. Harding, S. M. 1990. The human pharmacology of fluticasone propionate. Respir. Med. 84(Suppl. A):25-29.
17. Chervinsky, P., A. van As, E. A. Bronsky, R. Dockhom, M. Noonan, C. La Force, and W. Pleskow. 1994. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. J. Allergy Clin. Immunol. 94:676-683.
18. LaForce, C., P. Chervinsky, J. Seiner, J. Grossman, D. Pearlman, W. Schoenwetter, A. Schaberg, D. Kellerman, K. Kral, N. Herje, K. Trainer, and A. van As. 1993. Onset of action of inhaled corticosteriods in asthma (abstract). J. Allergy Clin. Immunol. 91:A223.
19. Barnes, N. C., and S. L. Payne. 1992. A multi-centre, randomised, double-blind parallel-group study to compare fluticasone propionate (FP) 1 mg daily with beclomethasone dipropionate (BDP) 2 mg daily in adult patients with severe asthma (abstract). Am. Rev. Respir. Dis. 145:A743.
20. Ware, J. E., Jr., and C. D. Sherbourne. 1992. The MOS 36-Item Short-Form Health Survey (SF-36). Med. Care 30:473-481.
21. Committee on Diagnostic Standards for Nontuberculosis Respiratory Diseases. 1962. Definitions and classification of chronic bronchitis, asthma and pulmonary emphysema. Am. Rev. Respir. Dis. 85:762-768.
22. van Elteren, P. H. 1960. On the combination of independent two-sample tests of Wilcoxon. Bulletin de l'Institut International de Statistique 37:351-361.
23. Gaddie, J., I. W. Reid, C. Skinner, G. R. Petrie, D. J. M. Sinclair, and K. N. V. Palmer. 1973. Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. Lancet 11:280-281.
24. Geddes, D. M. 1992. Inhaled corticosteriods: benefits and risks. Thorax 47:404-407.
25. Davies, G., P. Thomas, I. Broder, S. Mintz, F. Silverman, A. Leznoff, et al. 1977. Steroid-dependent asthma treated with inhaled beclomethasone dipropionate. Ann. Intern. Med. 86:549-553.
26. Webb, D. R. 1977. Beclomethasone in steroid-dependent asthma: effective therapy and recovery of hypothalamo-pituitary-adrenal function. J.A.M.A. 238:1508-1511.
27. Smith, M. J., and M. E. Hodson. 1983. High-dose beclomethasone inhaler in the treatment of asthma. Lancet 1:265-269.
28. Harvey, L. L., S. V. Nair, and I. Kass. 1976. Beclomethasone dipropionate aerosol in the treatment of steroid-dependent asthma. Chest 70:345-350.
29. Brompton Hospital/Medical Research Council Collaborative Trial. 1974. Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol in the treatment of chronic bronchial asthma. Lancet 10:303-307.
30. Smith, M. J. 1987. The place of high-dose inhaled corticosteroid in asthma therapy. Drugs 33:423-429.
31. Toogood, J. H., B. Jennings, J. Baskerville, and S. A. Johansson. 1982. Clinical use of spacer systems for corticosteroid inhalation therapy: a preliminary analysis. Eur. J. Respir. Dis. 63(Suppl. 122):100-107.
32. Hodson, M. E., J. C. Batten, S. W. Clarke, and I. Gregg. 1974. Beclomethasone dipropionate aerosol in asthma. Am. Rev. Respir. Dis. 110:403-408.
33. Fabbri, L., P. S. Burge, L. Croonenborgh, F. Warlies, B. Wecke, A. Ciaccia, and C. Parker. 1993. Comparisons of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 48:817-823.
34. Kerigan, A. T., S. O. Pugsley, D. W. Cockcroft, and F. E. Hargreave. 1977. Substitution of inhaled beclomethasone dipropionate for ingested prednisone in steroid-dependent asthmatics. CMA Journal 116:867-870.